Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

25 year–67 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Alexandroupolis

Alexandroupoli, Evros, 68100, Greece

About this study

The following dimensions will be recorded

Overall physician's empathy regarding generics in glaucoma
Physician's prescribing habits regarding generics in glaucoma
Physician's perceptions regarding generics cost-effectiveness in glaucoma
Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma)
Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Licensed Registration to Greek Ophthalmology Council

Exclusion criteria

Treatment and study plan

Primary outcomes

Generic Perception

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Democritus University of Thrace

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2013
First posted: May 17, 2013
Registry last updated: Jan 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed